Serious Bacterial Infection Risk in Febrile Infants Aged ≤90 Days With COVID-19

Rufu Furuya • Shun Kishibe • Takahiro Itagaki • et. al., DOI: 10.7759/cureus.87938  Abstract Background This retrospective cohort study compared the risk of serious bacterial infection (SBI) in febrile infants aged ≤90 days with and without COVID-19.…[...]

Read More

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Published:April 20, 2022DOI:https://doi.org/10.1016/j.molmed.2022.04.0 Authors: oannis P. Trougakos Evangelos Terpos Harry Alexopoulos Efstathios Kastritis Evangelos Andreakos Meletios A. Dimopoulos Highlights Coronavirus disease 2019 (COVID-19) mRNA vaccines induce robust immune responses against…[...]

Read More

Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance

Authors: Katherine E. Fleming-Dutra, MD1; Amadea Britton, MD1,2; Nong Shang, PhD1; et al May 13, 2022 JAMA. Published online May 13, 2022. doi:10.1001/jama.2022.7493 Key Points Question  Does the estimated effectiveness of 2 doses of the BNT162b2 COVID-19 vaccine against symptomatic SARS-CoV-2…[...]

Read More